Bedrijfstakpensioenfonds Voor DE Media PNO cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 10.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,150 shares of the medical equipment provider’s stock after selling 7,000 shares during the quarter. Intuitive Surgical comprises approximately 3.9% of Bedrijfstakpensioenfonds Voor DE Media PNO’s holdings, making the stock its 6th biggest position. Bedrijfstakpensioenfonds Voor DE Media PNO’s holdings in Intuitive Surgical were worth $31,328,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the third quarter worth $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the fourth quarter worth $36,000. Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical in the third quarter valued at about $38,000. Finally, DT Investment Partners LLC boosted its position in shares of Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after acquiring an additional 36 shares during the period. 83.64% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on ISRG shares. Citigroup boosted their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Raymond James boosted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Truist Financial boosted their price target on Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 18th. Finally, Royal Bank of Canada boosted their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.
Insider Buying and Selling at Intuitive Surgical
In other news, EVP Robert Desantis sold 1,012 shares of the firm’s stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $514.00, for a total transaction of $520,168.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,830,084. This trade represents a 15.53 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 43,509 shares of company stock valued at $22,602,212. 0.80% of the stock is currently owned by company insiders.
Intuitive Surgical Stock Performance
NASDAQ:ISRG opened at $604.12 on Wednesday. The company has a market capitalization of $215.18 billion, a PE ratio of 97.13, a P/E/G ratio of 5.04 and a beta of 1.39. The company has a 50 day simple moving average of $541.80 and a two-hundred day simple moving average of $500.76. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $606.27.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Differences Between Momentum Investing and Long Term Investing
- SAP’s Strong Momentum: A Bullish Setup for Investors
- How to Use the MarketBeat Dividend Calculator
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What Investors Need to Know About Upcoming IPOs
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.